Hyperlipidaemia after successful renal transplantation. (Q53831423)

20 May 2018

title

Hyperlipidaemia after successful renal transplantation. (English)

1 reference

20 May 2018

1 reference

A Casaretto

1

1 reference

20 May 2018

T L Marchioro

series ordinal

2

1 reference

20 May 2018

R Goldsmith

series ordinal

3

1 reference

20 May 2018

D Bagdade

series ordinal

4

1 reference

20 May 2018

language of work or name

English

0 references

publication date

1 March 1974

1 reference

20 May 2018

published in

The Lancet

1 reference

20 May 2018

volume

1

1 reference

20 May 2018

issue

7856

1 reference

20 May 2018

page(s)

481-484

1 reference

20 May 2018

Uremia (first of two parts). Uremia. I.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Hypertriglyceridemia. A metabolic consequence of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Plasma insulin disturbances in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. 3. Evaluation of parathyroid suppressibility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Hyperlipoproteinemia in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Type 3 hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Survival of patients undergoing chronic hemodialysis and renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Acute Insulin Withdrawal and the Regulation of Plasma Triglyceride Removal in Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Role of Insulin in Endogenous Hypertriglyceridemia*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Accelerated triglyceride secretion. A metabolic consequence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Effect of Glucocorticoids on Plasma Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Hyperglucagonism induced by glucocorticoid treatment in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

Glucagon resistance as a hormonal basis for endogenous hyperlipaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2874%2992787-1

7 January 2021

10.1016/S0140-6736(74)92787-1

Identifiers

DOI

1 reference

20 May 2018

PubMed ID

4131885

1 reference

20 May 2018